
1 - 10 employees
Founded 2017
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $100M Private Equity Round on 2022-04
Healthcare • Biotechnology • Pharmaceuticals
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
📡 We watch Dianthus Therapeutics, Inc.'s careers page
Every 2 hours
how often we check
3
roles posted in the last 30 days
About 50 days
usual time to fill a role
39
roles closed in the last year
Selected: 🆕 Date Added.
🕒 2 days ago
VP Corporate Controller leading accounting, SEC reporting, SOX compliance, and commercialization readiness. Building scalable financial infrastructure for an autoimmune therapeutics developer.
🇺🇸 United States – Remote
💵 Estimated: $206k - $297k / year
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 13%
🕒 November 6
QA leader overseeing biologics and combination-product manufacturing, quality systems, and regulatory submissions. Supporting Dianthus Therapeutics’ autoimmune disease therapies through CMO and CTO oversight.
🇺🇸 United States – Remote
💵 Estimated: $180k - $222k / year
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🔴 Lead
🔧 QA Engineer (Quality Assurance)
👻 Ghost score 13%
🕒 November 2
Senior Purchasing and Accounts Payable Associate managing purchasing and payables for Dianthus Therapeutics’ autoimmune disease therapy programs. Maintaining NetSuite purchase orders, invoices, vendors, and financial close support.
🇺🇸 United States – Remote
💵 Estimated: $55k - $100k / year
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟢 Junior
🟡 Mid-level
📝 Accounts Payable
👻 Ghost score 13%
🕒 October 9
Senior MSL advancing Dianthus Therapeutics’ neuromuscular disease portfolio. Building scientific relationships, supporting clinical trials, and informing evidence generation and launch readiness.
🇺🇸 United States – Remote
💵 Estimated: $173k - $212k / year
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🟠 Senior
✨ Medical Science Liaison
👻 Ghost score 13%
🕒 October 2
Executive Director leading bioanalytical strategy, assays, teams, and external partners at Dianthus Therapeutics. Supporting autoimmune therapy research, clinical development, and regulatory submissions.
🇺🇸 United States – Remote
💵 Estimated: $187k - $235k / year
💰 $100M Private Equity Round on 2022-04
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 13%